COMMUNIQUÉS West-GlobeNewswire

-
Glass House Brands to Hold Investor Sesh IV on Friday, June 20th
12/05/2025 -
ArriVent BioPharma Reports First Quarter 2025 Financial Results
12/05/2025 -
ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
12/05/2025 -
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)
12/05/2025 -
Allarity Therapeutics Announces Participation in Pharma Partnering Summit US
12/05/2025 -
Transactions under Novonesis’ share buyback program
12/05/2025 -
Herpesyl Under Review: Does This Herpes Supplement Really Work for Herpes Virus Symptoms?
12/05/2025 -
Trading by management and close relations of management
12/05/2025 -
Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate Asthma
12/05/2025 -
CONVENING NOTICE TO THE ORDINARY GENERAL MEETING 2025 OF IBA SA
12/05/2025 -
CONVOCATION À L’ASSEMBLÉE GÉNÉRALE ORDINAIRE 2025 D’IBA SA
12/05/2025 -
AB Science reports its revenues for the year 2024 and provides an update on its activities
12/05/2025 -
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2024 et présente un point sur ses activités
12/05/2025 -
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
12/05/2025 -
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
12/05/2025 -
Nanobiotix participera à la 3ème conférence investisseurs annuelle H.C. Wainwright BioConnect au NASDAQ
12/05/2025 -
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
12/05/2025 -
Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
12/05/2025 -
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
12/05/2025
Pages